Tradestie Institutional Equity Comparison Engine · Market Close May 26, 2026

IPOD vs CCCX: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

IPOD Captures Overall Composite Edge (58.0 HOLD vs 49.3 HOLD), While CCCX Leads 2–1 on Growth & Valuation Pillars

IPOD Overall Winner 6-Pillar Tally: IPOD 1 – 2 CCCX (3 Tie) Matrix Metrics: IPOD 4 – 1 CCCX

As of May 26, 2026, IPOD (IPOD) captures the overall head-to-head institutional edge over Churchill Capital Corp X Class A (CCCX) on higher Unified Composite conviction (58.0/100 HOLD vs. 49.3/100 HOLD) after splitting the core matrix 4–1 (led by Valuation Multiples), while CCCX wins 2–1 across the 6-pillar growth and valuation breakdown. IPOD trades at $10.42 (N/M Forward P/E, 0.0% operating margin) versus CCCX at $13.66 (N/M Forward P/E, 0.0% operating margin).

  • Growth vs. Quality Trade-Off: IPOD earns the overall head-to-head edge with a stronger Unified Composite Score (58.0/100 HOLD vs. CCCX 49.3/100 HOLD) and 0.00β · 2% Vol risk profile, whereas CCCX leads top-line expansion (+0.0% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About IPOD vs CCCX
IPOD US Equity Head-to-Head Winner
IPOD
Institutional Equity
$10.42
+0.39% 1D
Market Cap $210.0M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.00β · 2% Vol
Unified Composite Score
58.0 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Trend telemetry aligned with daily close.
RSI-14: N/A · SMA20: N/A · SMA50: N/A
CCCX NASDAQ
Churchill Capital Corp X Class A Ordinary Shares
Blank Checks
$13.66
+3.37% 1D
Market Cap $902.0M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 2.67β · 127% Vol
Unified Composite Score
49.3 / 100 HOLD
Tech 25.0 Fund 43.0 Flow 59.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 46
RSI-14: 46.1 · SMA20: $14.57 · SMA50: $15.48

6-Pillar Scorecard Institutional Category Breakdown (IPOD 1 – 2 CCCX)

Columns: Metric · IPOD · CCCX
1. Valuation Multiples IPOD
Forward P/E N/M N/M
Trailing P/E 39.9x N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale CCCX
Revenue Growth (YoY) +0.0% +0.0%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) N/A N/A
Market Cap $210.0M $902.0M
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin 0.0% 0.0%
Net Profit Margin 0.0% 0.0%
Return on Equity (ROE) 0.0% 0.0%
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage 0.0% ROE 0.0% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning CCCX
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 152.5% (86th %ile)
Put/Call OI Skew N/A 0.60x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Shell Companies Operator Shell Companies Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: IPOD (4) vs CCCX (1)
Institutional Metric IPOD CCCX Criterion Row Edge
Market Capitalization
Scale
$210.0M $902.0M Larger Scale CCCX
Trailing P/E Ratio
Valuation
39.9x N/M Lower Multiple IPOD
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+0.0% +0.0% Higher Growth Tie
Operating Margin (TTM)
Profitability
0.0% 0.0% Higher Margin Tie
Net Profit Margin
Profitability
0.0% 0.0% Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
0.0% 0.0% Higher ROE Tie
52-Week Range Position
Momentum
100% ($10–$10) 21% ($10–$28) Stronger Trend IPOD
Beta / 30D Volatility
Risk Regime
0.00β · 2% Vol 2.67β · 127% Vol Lower Realized Risk IPOD
Unified Institutional Score
Composite Signal
58.0 / 100 (HOLD) 49.3 / 100 (HOLD) Higher Composite IPOD
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (0.0% ROE) N/A (0.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon IPOD +7.63 pp
IPOD: +0.68% · CCCX: -6.95%
3M Horizon CCCX +32.79 pp
IPOD: +2.39% · CCCX: +35.18%
6M Horizon CCCX +31.27 pp
IPOD: +2.39% · CCCX: +33.66%
1Y Horizon CCCX +31.27 pp
IPOD: +2.39% · CCCX: +33.66%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IPOD vs CCCX. Trailing 12-month operating profitability (IPOD 0.0% vs CCCX 0.0%) and valuation multiples (IPOD N/M vs CCCX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

IPOD ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E0.0% · N/M
CCCX ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E0.0% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
IPOD UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact IPOD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CCCX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 152.5%
IV Percentile 86th %ile
Put/Call OI Skew 0.60x (Call-Skewed)
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CCCX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
IPOD Moat Profile Cyclical / Execution-Driven Positioning
Shell Companies Operator
Competes within the Shell Companies value chain with $210.0M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
CCCX Moat Profile Cyclical / Execution-Driven Positioning
Shell Companies Operator
Competes within the Shell Companies value chain with $902.0M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ IPOD vs CCCX Key Questions & Quantitative Answers

As of May 26, 2026, IPOD (IPOD) captures the overall head-to-head institutional edge over Churchill Capital Corp X Class A (CCCX) on higher Unified Composite conviction (58.0/100 HOLD vs. 49.3/100 HOLD) after splitting the core matrix 4–1 (led by Valuation Multiples), while CCCX wins 2–1 across the 6-pillar growth and valuation breakdown. IPOD trades at $10.42 (N/M Forward P/E, 0.0% operating margin) versus CCCX at $13.66 (N/M Forward P/E, 0.0% operating margin). Growth vs. Quality Trade-Off: IPOD earns the overall head-to-head edge with a stronger Unified Composite Score (58.0/100 HOLD vs. CCCX 49.3/100 HOLD) and 0.00β · 2% Vol risk profile, whereas CCCX leads top-line expansion (+0.0% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.

CCCX leads the Growth & Scale pillar: IPOD posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with CCCX at +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, IPOD generates N/A in USD-normalized revenue versus N/A for CCCX. In operating R&D and SG&A reinvestment, IPOD deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for CCCX.

IPOD screens cheaper on headline valuation multiples. IPOD trades at N/M Forward P/E, 39.9x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas CCCX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against IPOD (0.0% ROE) versus CCCX (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, IPOD carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.00β · 2% Vol realized risk). By comparison, CCCX carries 152.5% implied volatility (86th %ile, Extreme (>80th %ile)), a 0.60x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.67β · 127% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of May 26, 2026. For educational research only; not investment advice.